The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient
NCT ID: NCT03117075
Last Updated: 2017-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
68 participants
INTERVENTIONAL
2017-05-15
2018-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023
Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients
NCT03155516
Utility of an APP for the Monitoring of Irruptive Oncological Pain
NCT03597737
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225
Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients
NCT03895762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
using device for scoring pain scale, named "ANAPA®"
using device for scoring pain scale, named "ANAPA®"
wearable device for scoring pain scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
using device for scoring pain scale, named "ANAPA®"
wearable device for scoring pain scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cancer pain with visual analog scale or numeric rating scale score \>/- 4
* opioids candidates
* with informed consent form
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DERSHENG SUN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DERSHENG SUN
clinical assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
YOONHO KO, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Uijeongbu St. Mary's Hospital, The Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daejeon St. Mary's Hospital, the Catholic University of Korea
Daejeon, , South Korea
Seoul St. Mary's Hospital, the Catholic University of Korea
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XC15EIMI0099KUD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.